International Creatine Conference 2022
The International Conference on Creatine in Health and Disease 2022, March 16-19, will bring together the world's leading creatine researchers to discuss the role of creatine supplementation in health as well as clinical treatment of disease. Health, exercise, nutrition and wellness experts, young researchers, entrepreneurs and students from around the world are invited.
The digital conference is hosted by the Scientific Advisory Board "Creatine in Health" of Alzchem Group AG - Creapure®, the Exercise and Sport Nutrition Laboratory Texas A&M and the Dynamical Business & Science Society - DBSS International.
Creatine supplementation is one of the most studied and effective nutritional supplements for athletes. Among the many positive effects of creatine is an increase in energy capacity, which in turn results in more muscle mass and increased physical performance. While these widely recognized effects have so far benefited both competitive and recreational athletes, creatine can also serve as a potential clinical and therapeutic treatment for conventional medical topics. Several studies have examined the positive effects of creatine supplementation on conditions such as diabetes, sarcopenia, osteoporosis, and cancer, on rehabilitation, and on pulmonary and cardiovascular health.
The 2022 International Creatine Conference will be held March 16-19, 2022, as an online-only event. To view the agenda.
For speaker information:
Please register here.
Conference attendance counts as continuing education under CME and CEU.
The Scientific Advisory Board "Creatine in Health" of Alzchem Group AG - Creapure®, the Exercise and Sport Nutrition Laboratory at Texas A&M and the Dynamical Business & Science Society - DBSS International are looking forward to seeing you!
Contact
Dr. Jürgen Bezler
About Alzchem
Alzchem is a globally active specialty chemicals company that is predominantly among the market leaders in its fields of activity. Alzchem benefits in particular from the three very different global developments of climate change, population growth and longer life expectancy. In order to achieve the resulting social goals, Alzchem products can offer attractive solutions with a wide range of different applications.
The company sees interesting growth prospects for itself especially in the areas of human and animal nutrition and agriculture. As a result of population growth, it is necessary to achieve efficient food production. Pharmaceutical raw materials and our creatine products can contribute to healthy aging as life expectancy increases. Alzchem is facing up to the goal of sustainability arising from climate change in the field of renewable energies and across the entire company. The fields of fine chemicals and metallurgy offer just as great a perspective.
The broad product range of Alzchem Group AG includes dietary supplements, precursors for corona tests and pharmaceutical raw materials. These products are our company’s response to global trends and developments. Alzchem is ideally positioned in this regard and sees itself as well equipped for an environmentally oriented future and global developments.
The company employs around 1,630 people at four production sites in Germany and one plant in Sweden, as well as two sales companies in the USA and China. In 2020, Alzchem generated consolidated sales of around EUR 379 million and EBITDA of around EUR 53.8 million.